The use of fibrinolysis inhibitors in cardiac surgery with cardiopulmonary bypass (literature review)
In cardiac surgery with cardiopulmonary bypass (CPB) is a common complication. The incidence of this complication in cardiac surgery patients is estimated at about 10%. For this reason, the introduction of a patient blood management (PBM) in cardiac surgery is extremely relevant. Antifibrinolytic th...
Saved in:
| Main Authors: | V. Yu. Medvedeva, K. N. Khrapov, A. A. Khryapa, K. Yu. Kankova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2024-08-01
|
| Series: | Вестник анестезиологии и реаниматологии |
| Subjects: | |
| Online Access: | https://www.vair-journal.com/jour/article/view/1038 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of the efficacy and safety of aprotinin and tranexamic acid in cardiac surgery with cardiopulmonary bypass in adult patients
by: V. Yu. Medvedeva, et al.
Published: (2025-06-01) -
VALUE OF LOCAL ADMINISTRATION OF TRANEXAMIC ACID IN CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS
by: S. I. Sergey, et al.
Published: (2018-01-01) -
Population Pharmacokinetics of Tranexamic Acid in Chinese Population Undergoing Cardiac Surgery with Cardiopulmonary Bypass
by: Liu Y, et al.
Published: (2025-05-01) -
A technique avoiding cardioplegia delivery complications: a case using systemic hyperkalemia cardiopulmonary bypass combined with circulatory arrest
by: Takeichi Tomohisa, et al.
Published: (2024-12-01) -
Red Cell Distribution Width as a Predictive Biomarker for Early Lung Injury in Pediatric Patients Following Cardiopulmonary Bypass
by: Hui Liu, et al.
Published: (2025-06-01)